REGENXBIO Inc. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 22/100
What the filing says
On April 28, 2026, REGENXBIO RS LLC and lender HCR RGNX ROYALTY SPV, LP amended their May 16, 2025 loan agreement to clarify interest payment mechanics. The amendment redefines when royalty payments are deemed 'Included Royalty Interest' for quarterly calculations, specifies that accrued interest is payable in arrears on Interest Payment Dates, and clarifies that excess royalty interest above fixed interest accrues to principal repayment (Amortization Payments). No principal amount, interest rate, or loan size is disclosed in this amendment.
Why this rating
Technical clarification to existing loan mechanics; no new capital, no material financial change disclosed; administrative amendment to contract terms.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.